期刊文献+

ALDH1高表达对乳腺癌细胞MCF-7干细胞特性的影响 被引量:1

Expression and Significance of ALDH1 in Cancer Stem Cell-like Characteristics in Breast Cancer Cell Line MCF-7
下载PDF
导出
摘要 目的探讨ALDH1高表达对乳腺癌MCF-7细胞干细胞特性的影响,为乳腺癌的治疗提供理论依据。方法构建慢病毒ALDH1RNA,转染乳腺癌MCF-7细胞,嘌呤霉素筛选稳定高表达ALDH1的亚克隆,命名为MCF-ALDH1细胞株。荧光定量PCR和Western blot法检测MCF-ALDH1细胞株及对照细胞中ALDH1在mRNA和蛋白水平的表达;克隆形成实验、悬浮球形成实验及裸鼠成瘤实验检测MCF-ALDH1及对照组细胞的干细胞特性,MTT法测定细胞的耐药性。结果与MCF-7组细胞比较,MCF-ALDH1细胞株的ALDH1在mRNA和蛋白表达量明显升高;MCF-ALDH1细胞克隆形成数目为128±22个,高于MCF-ALDH1细胞球克隆形成数(46±15个);悬浮成球实验,MCF-ALDH1细胞悬浮成球数目明显增多(16±2个),高于对照细胞悬浮球数(8.0±1.5个);肿瘤细胞在裸鼠皮下接种后,MCF-7细胞组有3只裸鼠成瘤,MCF-ALDH1有5只成瘤,瘤体积明显大于MCF-7组,差异有统计学意义(P<0.05)。耐药实验显示,MCF-ALDH1对顺铂、紫杉醇的耐药性明显提高。结论高表达ALDH1的乳腺癌MCF-7细胞干细胞特性增强,ALDH1可能成为乳腺癌治疗的靶点之一。 Objective To investigate the expression and significance of ALDH1 in cancer stem cell-like characteristics in breast cancer cell line MCF-7. Methods RNA lenti-virus particles targeting ALDH1 gene were transfected into MCF-7 cells. Subclones with stable ALDH1 expression were selected by puromycin and named MCF-ALDH1 cells. The mRNA and protein expression of ALDH1 were detected by real-time quantitative PCR and Western blot tests. Cell differentiation,stem cell potential were observed by clone formation assay and suspension sphere-forming assay. The abilities of tumor-formation of cells were detected through inoculating the cells into the nod mouse. To detect the drug-resistance ability of cells by MTT test. Results Compared to the MCF-7 cells,the expression of mRNA and protein of ALDH1 by MCF-ALDH1 cells were significantly increased. Clony forming numbers( 128 ± 22) of the MCF-ALDH1 cells was higher than controls( 46 ± 15)( P〈0.05),The proportion of sphere-initiating cells in MCF-ALDH1 and controls was( 16 ± 2) versus( 8. 0 ± 1. 5,P〈0.05). The average tumor volume of MCF-ALDH1 was greater than controls( P〈0.05). The drug resistance index of MCF-ALDH1 was higher than controls. Conclusion Experimental findings from this study showed that MCF-7 cells highly expressing ALDH1 genes,with higher proliferation and differentiation,in vivo tumorigenicity and potential of stem cells. ALDH1 may be used as an target to cure breast cancer.
作者 冀峰 李克 Ji Feng;Li Ke(Department of Thyroid and Breast Surgery,The Center Hospital of Kaifeng,Henan 475003,China)
出处 《医学研究杂志》 2018年第6期68-71,共4页 Journal of Medical Research
基金 河南省科技厅基础与前沿项目(112300410044)
关键词 ALDH1 乳腺癌 干细胞特性 ALDH1 Breast cancer Stem cell- like characteristics
  • 相关文献

参考文献2

二级参考文献43

  • 1Velasco-Vel(:tzquez MA, Homsi N, De La Fuente M, et al. Breast cancer stem cells[ J ]. Int J Biochem Cell Biol, 2012, 44 (4) : 573 -577.
  • 2Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nat Med, 1997, 3(7) : 730-737.
  • 3A1-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells [ J ]. Proc Natl Acad Sci U S A, 2003, 100(7) : 3983-3988.
  • 4Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells [ J ] . Gastroenterology, 2007, 132 (7) : 2542-2556.
  • 5Ricardo S, Vieira AF, Gerhard R, et al. Breast cancer stem cell markers CD44, CD24 and ALDH1 : expression distribution within intrinsic molecular subtype[ J]. J Clin Pathol, 2011, 64 ( 11 ) : 937 -946.
  • 6Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [ J ] . Cell Stern Cell, 2007, 1(5) : 555-567.
  • 7Yoshioka T, Umekita Y, Ohi Y, et al. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study[ J]. Histopathology, 2011, 58(4) : 608-616.
  • 8Sakakibara M, Fujimori T, Miyoshi T, et al. Aldehyde dehydrogenase l-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer[ J]. Cancer, 2012, 118(16) : 3899- 3910.
  • 9Zhang M, Song T, Yang L, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients[J]. J Exp Clin Cancer Res, 2008, 27: 85.
  • 10Torch A, Bielorai B, Jacob-Hirsch J, et al. CD133-positive hematopoietic stem ceil "stemness" genes contain many genes mutated or abnormally expressed in leukemia [ J ]. Stem Cells, 2005, 23(8) : 1142-1153.

共引文献6

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部